Literature DB >> 36082368

Generation of a Human Conditionally Immortalized Cell-based Multicellular Spheroidal Blood-Brain Barrier Model for Permeability Evaluation of Macromolecules.

Ryuto Isogai1, Hanae Morio1, Ayaka Okamoto1, Keita Kitamura1, Tomomi Furihata1.   

Abstract

There is an urgent need for the development of brain drug delivery carriers based on middle-sized or macromolecules, to which in vitro blood-brain barrier (BBB) models are expected to contribute significantly through evaluation of BBB permeability. As part of efforts to develop such models, we have been working on human conditionally immortalized cell-based multicellular spheroidal BBB models (hiMCS-BBB models), and we herein introduce the model development protocol. Briefly, astrocytes are first seeded in an ultra-low attachment 3D cell culture plate, to make the central core (Day 0). Next, pericytes are added over the core, to form an outer layer (Day 1). Then, brain microvascular endothelial cells are further added to each well, to create the outmost monolayer serving as the BBB (Day 2). Finally, the spheroids cultured for two days (on Day 4) can be used for assays of interest (e.g., antibody permeability assays). Neither special equipment nor techniques are required to produce hiMCS-BBB models. Therefore, the protocol presented here will not only facilitate the model sharing among the BBB community but also provide some technical clues contributing to the development of similar MCS-BBB models using other cell sources, such as primary or iPS-derived BBB cells. Graphical abstract.
Copyright © 2022 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Blood-brain barrier; Central nervous system; Drug development; Immortalized cell; In vitro model; Microphysiological systems; Receptor-mediated transcytosis; Spheroid

Year:  2022        PMID: 36082368      PMCID: PMC9411012          DOI: 10.21769/BioProtoc.4465

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  24 in total

1.  Differentiated HASTR/ci35 cells: A promising in vitro human astrocyte model for facilitating CNS drug development studies.

Authors:  Keita Kitamura; Ryo Ito; Kenta Umehara; Hanae Morio; Kosuke Saito; Shota Suzuki; Mari Hashimoto; Yoshiro Saito; Naohiko Anzai; Hidetaka Akita; Kan Chiba; Tomomi Furihata
Journal:  J Pharmacol Sci       Date:  2018-08-09       Impact factor: 3.337

Review 2.  Antibody therapies in CNS diseases.

Authors:  Per-Ola Freskgård; Eduard Urich
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

Review 3.  Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier.

Authors:  Jason M Lajoie; Eric V Shusta
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

4.  A New Conditionally Immortalized Human Fetal Brain Pericyte Cell Line: Establishment and Functional Characterization as a Promising Tool for Human Brain Pericyte Studies.

Authors:  Kenta Umehara; Yuchen Sun; Satoshi Hiura; Koki Hamada; Motoyuki Itoh; Keita Kitamura; Motohiko Oshima; Atsushi Iwama; Kosuke Saito; Naohiko Anzai; Kan Chiba; Hidetaka Akita; Tomomi Furihata
Journal:  Mol Neurobiol       Date:  2017-11-11       Impact factor: 5.590

5.  A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.

Authors:  Ryo Ito; Kenta Umehara; Shota Suzuki; Keita Kitamura; Ken-Ichi Nunoya; Yoshiyuki Yamaura; Haruo Imawaka; Saki Izumi; Naomi Wakayama; Takafumi Komori; Naohiko Anzai; Hidetaka Akita; Tomomi Furihata
Journal:  Mol Pharm       Date:  2019-10-15       Impact factor: 4.939

6.  Establishment of a new conditionally immortalized cell line from human brain microvascular endothelial cells: a promising tool for human blood-brain barrier studies.

Authors:  Atsuko Kamiichi; Tomomi Furihata; Satoshi Kishida; Yuki Ohta; Kosuke Saito; Shinya Kawamatsu; Kan Chiba
Journal:  Brain Res       Date:  2012-10-03       Impact factor: 3.252

7.  Establishment and characterization of a new conditionally immortalized human astrocyte cell line.

Authors:  Tomomi Furihata; Ryo Ito; Atsuko Kamiichi; Kosuke Saito; Kan Chiba
Journal:  J Neurochem       Date:  2015-10-08       Impact factor: 5.372

8.  Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.

Authors:  Claire Simonneau; Martina Duschmalé; Alina Gavrilov; Nathalie Brandenberg; Sylke Hoehnel; Camilla Ceroni; Evodie Lassalle; Elena Kassianidou; Hendrik Knoetgen; Jens Niewoehner; Roberto Villaseñor
Journal:  Fluids Barriers CNS       Date:  2021-09-20

Review 9.  Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives.

Authors:  Aida Kouhi; Vyshnavi Pachipulusu; Talya Kapenstein; Peisheng Hu; Alan L Epstein; Leslie A Khawli
Journal:  Int J Mol Sci       Date:  2021-06-16       Impact factor: 5.923

10.  A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport.

Authors:  Nienke R Wevers; Dhanesh G Kasi; Taylor Gray; Karlijn J Wilschut; Benjamin Smith; Remko van Vught; Fumitaka Shimizu; Yasuteru Sano; Takashi Kanda; Graham Marsh; Sebastiaan J Trietsch; Paul Vulto; Henriëtte L Lanz; Birgit Obermeier
Journal:  Fluids Barriers CNS       Date:  2018-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.